CHPJ Articles
Showing 13–24 of 166 resultsSorted by latest
-
Les programmes d’importation des États-Unis sont irréalistes : détourner les médicaments d’ordonnance vers les consommateurs américains épuiserait rapidement l’approvisionnement en médicaments au Canada
Read more -
Government development of ‘made-in-Canada’ CAR-T cell immunotherapies: assessing cost, risk, access, and alternatives
Read more -
Identifying Spasticity Treatment Gaps in Long-term Care and Community Settings from Ontario Real-world Evidence
Read more -
Community Trust and Public Health Compliance: COVID-19 Experiences in Newfoundland and Labrador
Read more -
Benefit of expedited regulatory approval for oncology drugs eliminated by slow reimbursement reviews and price negotiations
Read more -
Exploring the Ethics of Paediatric Surgical Prioritization in Canada: A Survey of Existing Institutional Guidance
Read more -
Effects of the COVID-19 pandemic on the number and characteristics of public drug program beneficiaries in Ontario, Canada
Read more -
A Growing Problem: Is Canada’s Healthcare System Keeping Up with Newcomers?
Read more -
A Canadian Healthcare Policy Framework for Clinical Care at the End and the Beginning of Life: Prioritization, Human Resource Management, and Remuneration Models
Read more -
Public v private insurance coverage for new drugs in Canada, 2018-2023, 7th Edition
Read more -
Waiting for new medicines in Canada, Europe, and the United States 2018-2023
Read more -
Patented Medicines Expenditure in Canada 1990–2022 8TH Edition
Read more